Endo Int'l Receives Notification Eagle Pharma Has Submitted ANDA to FDA Seeking Approval For A Generic Version of Vasostrict; Endo Says It Intends to 'Vigorously Protect Its Intellectual Property,' Including Potentially Filing Patent Infringement Lawsuit